IDL Diagnostics AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	52.19	57.44	43.04	36.99	12	0.08
Revenue	52.19	57.44	43.04	36.99	12	0.08
Revenue Growth (YoY)	1.18%	33.45%	16.37%	208.32%	14180.95%	-81.04%
Cost of Revenue	45.89	45.7	45.14	39.09	17.04	0.02
Gross Profit	6.3	11.74	-2.1	-2.11	-5.05	0.06
Selling, General & Admin	33.11	33.82	33.07	35.82	26	11.47
Research & Development	22.82	22.79	25.24	24.43	19.83	12.6
Other Operating Expenses	-0.29	-0.29	-0.42	-2.23	-0.06	-0.01
Operating Expenses	55.64	56.32	57.9	58.02	45.77	24.06
Operating Income	-49.34	-44.58	-60	-60.12	-50.82	-24
Interest Expense	-	-0	-0.01	-0.01	-	-
Interest & Investment Income	0.51	0.98	0.5	0.01	-	-
Currency Exchange Gain (Loss)	-0.24	1.15	0.21	0.82	0.24	-0.06
Other Non Operating Income (Expenses)	0	-	-	-0	-	-
Pretax Income	-49.06	-42.45	-59.3	-59.3	-50.57	-24.05
Earnings From Continuing Operations	-49.06	-42.45	-59.3	-59.3	-50.57	-24.05
Minority Interest in Earnings	-	-	-	0.33	0.55	-
Net Income	-49.06	-42.45	-59.3	-58.97	-50.03	-24.05
Net Income to Common	-49.06	-42.45	-59.3	-58.97	-50.03	-24.05
Shares Outstanding (Basic)	230	230	230	215	94	74
Shares Outstanding (Diluted)	230	230	230	215	94	74
Shares Change (YoY)	-	-	6.97%	128.22%	28.18%	86.72%
EPS (Basic)	-0.21	-0.18	-0.26	-0.27	-0.53	-0.33
EPS (Diluted)	-0.21	-0.18	-0.26	-0.27	-0.53	-0.33
Free Cash Flow	-6.12	-2.5	-13.93	-16.72	-28.21	-18.96
Free Cash Flow Per Share	-0.03	-0.01	-0.06	-0.08	-0.30	-0.26
Gross Margin	12.08%	20.43%	-4.88%	-5.69%	-42.06%	75.00%
Operating Margin	-94.54%	-77.62%	-139.40%	-162.55%	-423.61%	-28565.48%
Profit Margin	-94.01%	-73.91%	-137.78%	-159.45%	-417.01%	-28633.33%
Free Cash Flow Margin	-11.72%	-4.35%	-32.38%	-45.20%	-235.13%	-22565.48%
EBITDA	-8.49	-1.41	-14.46	-12.94	-30.51	-23.67
EBITDA Margin	-16.27%	-2.45%	-33.60%	-34.99%	-254.30%	-
D&A For EBITDA	40.85	43.18	45.54	47.18	20.31	0.32
EBIT	-49.34	-44.58	-60	-60.12	-50.82	-24
EBIT Margin	-94.53%	-77.62%	-139.40%	-162.55%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.